Results 121 to 130 of about 62,786 (347)

Burst steroid therapy and quality of life in patients with acute heart failure: Insights from the CORTAHF trial

ESC Heart Failure, EarlyView.
Abstract Aims Patients hospitalized with acute heart failure (AHF) treated with a 7 day prednisone course in the CORTAHF pilot trial had a greater improvement in health‐related quality of life (QoL) at Day 7 in both the overall population and in patients with baseline interleukin 6 > 13 pg/mL.
Matteo Pagnesi, Gad Cotter, Beth A. Davison, Yonathan Freund, Adriaan A. Voors, Christopher Edwards, Maria Novosadova, Koji Takagi, Hamlet Hayrapetyan, Andranik Mshetsyan, Mayranush Drambyan, Alain Cohen‐Solal, Jozine M. ter Maaten, Jan Biegus, Piotr Ponikowski, Gerasimos Filippatos, Ovidiu Chioncel, Malha Sadoune, Tabassome Simon, Douglas L. Mann, Alexandre Mebazaa, Marco Metra   +21 more
wiley   +1 more source

Treatment of Heart Failure with Sodium-glucose Cotransporter Type 2 Inhibitors

Medisur
Heart failure is a chronic disease that affects millions of people worldwide and is a leading cause of death. Sodium-glucose cotransporter type 2 inhibitors are a new class of drugs that have demonstrated cardiovascular benefits in patients with type 2 ...
Riber Fabián Donoso Noroña, Nairovys Gómez Martínez, Adisnay Rodríguez Plasencia   +2 more
doaj  

Purification of a putative Na⁺ /D‐glucose cotransporter from pig kidney brush border membranes on a phlorizin affinity column [PDF]

, 1988
Tomas Kitlar, Alison I. Morrison, Rolf Kinne, Josef Deutscher   +3 more
openalex   +1 more source

Right ventricular dysfunction for prediction of long‐term recovery in de novo HFrEF : a PROLONG‐II substudy

ESC Heart Failure, EarlyView.
Abstract Aims To analyse the predictive value of advanced markers of right ventricular (RV) function and RV‐pulmonary arterial (PA) coupling in forecasting long‐term left ventricular (LV) improvement in de novo heart failure with reduced ejection fraction (HFrEF).
Aiste Monika Jakstaite, Johanna Mueller‐Leisse, Henrike A.K. Hillmann, Stephan Hohmann, Jörg Eiringhaus, Udo Bavendiek, Tibor Kempf, Christian Veltmann, Johann Bauersachs, David Duncker, D. Berliner   +10 more
wiley   +1 more source

Continual evolution of type 2 diabetes: an update on pathophysiology and emerging treatment options

Therapeutics and Clinical Risk Management, 2015
Susan Cornell Chicago College of Pharmacy, Midwestern University, Downers Grove, IL, USA Abstract: Diabetes is a complex and progressive disease that has a major societal and economic impact.
Cornell S
doaj  

Effects of a sodium‐glucose cotransporter 2 inhibitor in nonalcoholic fatty liver disease complicated by diabetes mellitus: Preliminary prospective study based on serial liver biopsies

Hepatology Communications, 2017
A prospective study based on serial liver biopsies was performed to investigate the efficacy of sodium‐glucose cotransporter 2 inhibitor for nonalcoholic fatty liver disease complicated with type 2 diabetes mellitus.
N. Akuta, Chizuru Watanabe, Y. Kawamura, Y. Arase, S. Saitoh, Shunichiro Fujiyama, H. Sezaki, T. Hosaka, M. Kobayashi, M. Kobayashi, Yoshiyuki Suzuki, F. Suzuki, K. Ikeda, H. Kumada   +13 more
semanticscholar   +1 more source

Prediction of 90 day mortality in elderly patients with acute HF from e‐health records using artificial intelligence

ESC Heart Failure, EarlyView.
Abstract Aims Mortality risk after hospitalization for heart failure (HF) is high, especially in the first 90 days. This study aimed to construct a model automatically predicting 90 day post‐discharge mortality using electronic health record (EHR) data 48 h after admission and artificial intelligence. Methods All HF‐related admissions from 2015 to 2020
Joconde Weller, Johann Gutton, Guillaume Hocquet, Leïla Pellet, Marie‐José Aroulanda, Amélie Bruandet, Didier Theis, Fabio Boudis, Romain Cador, Pierre Zweigenbaum, Anne Buronfosse, Pascal de Groote, Michel Komajda   +12 more
wiley   +1 more source

Global myocardial work index predicts response to biventricular pacing in patients with non‐left bundle branch block

ESC Heart Failure, EarlyView.
Abstract Aims Cardiac resynchronization therapy (CRT) improves the prognosis of patients with heart failure (HF) and wide QRS complex. However, patients with non‐left bundle branch block (LBBB) show a poor response to CRT. This study evaluated myocardial work estimated by pressure–strain loops on echocardiography for predicting response to CRT in ...
Shun Kondo, Yasuya Inden, Satoshi Yanagisawa, Kiichi Miyamae, Hiroyuki Miyazawa, Takayuki Goto, Masaya Tachi, Tomoya Iwawaki, Ryota Yamauchi, Kei Hiramatsu, Masafumi Shimojo, Yukiomi Tsuji, Toyoaki Murohara   +12 more
wiley   +1 more source

Clinical utility and safety of finerenone in patients with heart failure: Rationale and design of FINE registry

ESC Heart Failure, EarlyView.
Abstract Aims Information about current use of finerenone in patients with heart failure (HF) finerenone in clinical practice is scarce, and its effectiveness in clinical practice in patients is scarce. We aim to assess both the baseline clinical profile and prognostic role of finerenone in patients with HF, irrespective of ejection fraction.
Gonzalo Luis Alonso Salinas, Amaia Martínez León, Diego Aguiar Cano, Alberto Esteban‐Fernández, José María Viéitez Flórez, Susana del Prado Díaz, Juan Górriz‐Magaña, Gregorio de Lara Delgado, Rafael González‐Manzanares, Pedro Caravaca‐Pérez, Francisco J. Pastor‐Pérez, Sandra Valdivieso‐Moré, Juan Quiles, Inés Ponz, Vanessa Escolar, Edison Omar Boada Lincango, Néstor Báez‐Ferrer, Gonzalo Gallego, Luis Almenar, Luis Gutiérrez de la Varga, Pau Codina, Alejandro Recio Mayoral, Aleix Fort, María Jesús Pinilla Lozano, David González‐Calle, Inés Gómez‐Otero, Cristina Salazar Mosteiro, Marta Cobo, Jesús Piqueras‐Flores, Clara Bonanad, Ana Huerta, Maria Ferré Vallverdú, Pablo Díez‐Villanueva   +32 more
wiley   +1 more source

Early administration of dapagliflozin preserves pancreatic β‐cell mass through a legacy effect in a mouse model of type 2 diabetes

Journal of Diabetes Investigation, 2019
Aims/Introduction The preservation of pancreatic β‐cell mass is an essential factor in the onset and development of type 2 diabetes mellitus. Recently, sodium–glucose cotransporter 2 inhibitors have been launched as antihyperglycemic agents, and their ...
Ayumi Kanno, Shun‐ichiro Asahara, Mao Kawamura, Ayuko Furubayashi, Shoko Tsuchiya, Emi Suzuki, Tomoko Takai, Maki Koyanagi‐Kimura, Tomokazu Matsuda, Yuko Okada, Wataru Ogawa, Yoshiaki Kido   +11 more
doaj   +1 more source